文献速递肺外科

肺段切除与肺叶切除治疗临床IA期伴STAS肺腺癌的预后比较

Segmentectomy vs Lobectomy for Clinical Stage IA Lung Adenocarcinoma With Spread Through Air Spaces.
PubMed 文献 · Ann Thorac Surg · 2020-11-02

本研究回顾性纳入609例临床IA期肺腺癌患者,比较肺段切除与肺叶切除的预后。STAS阳性者293例(48.1%),STAS阳性患者RFS显著差于阴性者。在STAS阳性患者中,肺段切除与肺叶切除的RFS无显著差异,倾向性评分多变量分析显示肺段切除不是RFS的独立预后因素。

要点

  • STAS阳性是临床IA期肺腺癌的不良预后因素。
  • STAS阳性患者中肺段切除与肺叶切除的RFS无显著差异。
  • 肺段切除未增加STAS阳性患者的局部复发。

核心结论

  • STAS是临床IA期肺腺癌的不良预后因素。
  • 在STAS阳性肺腺癌中,肺段切除的预后与肺叶切除相当,且不增加局部区域复发。

研究设计与样本

  • 回顾性研究,纳入2011年4月至2020年3月在广岛大学医院接受肺叶切除或肺段切除加淋巴结清扫的临床IA期肺腺癌患者609例。

主要发现

  • STAS检出293例(48.1%)。
  • 肺叶切除组中,STAS阳性与阴性者的5年RFS分别为68.2%与90.2%(P < .001)。
  • 肺段切除组中,STAS阳性与阴性者的5年RFS分别为81.3%与93.0%(P = .003)。
  • STAS阳性患者中,肺叶切除与肺段切除的5年RFS分别为68.2%与81.3%(P = .225)。
  • 倾向性评分多变量分析显示,STAS阳性患者中肺段切除不是RFS的独立预后因素(风险比0.732,P = .326)。

临床怎么用

  • 对于临床IA期肺腺癌伴STAS,肺段切除可作为与肺叶切除相当的选项,但需注意切缘充分。

局限性

  • 回顾性研究,样本来自单中心。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to investigate the prognosis after segmentectomy as compared with lobectomy for small-sized lung adenocarcinoma with spread through air spaces (STAS). METHODS: This retrospective study included 609 patients who underwent lobectomy or segmentectomy with lymph node dissection for clinical stage IA lung adenocarcinoma between April 2011 and March 2020 at Hiroshima University Hospital. Patient characteristics and prognosis after segmentectomy and lobectomy were investigated. RESULTS: STAS was detected in 293 patients (48.1%). The recurrence-free survival (RFS) rate was significantly worse with STAS-positive adenocarcinoma than with STAS-negative adenocarcinoma both in patients who underwent lobectomy (5-year RFS, 68.2% vs 90.2%; P < .001) and in patients who underwent segmentectomy (5-year RFS, 81.3% vs 93.0%; P = .003). Among the patients with STAS, there was no significant difference in RFS between patients who underwent lobectomy (5-year RFS, 68.2%) and those who underwent segmentectomy (5-year RFS, 81.3%; P = .225). In a multivariable analysis using propensity score to adjust clinical patient characteristics, segmentectomy was not found to be an independent prognostic factor of RFS (hazard ratio 0.732, P = .326) among patients with STAS. Among the patients with STAS, only 1 patient (1%) with insufficient resection margin (0.5 mm) had local recurrence and 1 patient (1%) with invasive mucinous adenocarcinoma had recurrence in preserved lobe after segmentectomy. CONCLUSIONS: Spread through air spaces was a poor prognostic factor in patients with clinical stage IA lung adenocarcinoma. Prognosis after segmentectomy was comparable with that of lobectomy in lung adenocarcinoma with STAS without increasing locoregional recurrence.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Kagimoto A, Tsutani Y, Kushitani K, et al. Segmentectomy vs Lobectomy for Clinical Stage IA Lung Adenocarcinoma With Spread Through Air Spaces. Ann Thorac Surg. 2020. PMID: 33144104. doi:10.1016/j.athoracsur.2020.09.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。